<?xml version="1.0" encoding="UTF-8"?>
<p id="para0009">With the favourable in vitro antiviral activity of remdesivir, it has been further tested in animal models of different viral infections. In a rhesus monkey model of Ebola virus disease, daily administration of 10 mg/kg remdesivir for 12 days profoundly suppressed the replication of Ebola virus and protected all infected animals against this lethal infection 
 <xref rid="bib0015" ref-type="bibr">[15]</xref>. Besides, in a mouse model of SARS-CoV infection, prophylactic and early therapeutic dosing of remdesivir effectively decreased the viral load in the lungs and improved pulmonary function 
 <xref rid="bib0020" ref-type="bibr">[20]</xref>.
</p>
